RAU’s Respiratory Care Pharmacology
l l l
9TH EDITIONl
BY GARDENHIRE
l
TEST BANK l
,Description
Test lBank lfor lRau’s lRespiratory lCare lPharmacology l9th lEdition lGardenhire
Test lBank lfor lRau’s lRespiratory lCare lPharmacology, l9th lEdition, lGardenhire, lISBN-10:
l0323299687, lISBN-13: l9780323299688
Table lof lContents
Unit lI: lBasic lConcepts land lPrinciples lin lPharmacology
1. lIntroduction lto lRespiratory lCare lPharmacology
2. lPrinciples lof lDrug lAction
3. lAdministration lof lAerosolized lAgents
4. lCalculating lDrug lDoses
5. lThe lCentral land lPeripheral lNervous lSystems
Unit lII: lDrugs lUsed lto lTreat lthe lRespiratory lSystem
6. lAdrenergic l(Sympathomimetic) lBronchodilators
7. lAnticholinergic l(Parasympatholytic) lBronchodilators
8. lXanthines
9. lMucus-Controlling lDrug lTherapy
10. lSurfactant lAgents
11. lCorticosteriods lin lRespiratory lCare
12. lNonsteroidal lAntiasthma lAgents
13. lAerosolized lAntiinfective lAgents
14. lAntimicrobial lAgents
15. lCold land lCough lAgents
16. lSelected lAgents lof lPulmonary lValue
17. lNeonatal land lPediatric lAerosolized lDrug lTherapy
Unit lIII: lCritical lCare, lCardiovascular, land lPolysomnography lAgents
18. lSkeletal lMuscle lRelaxants l(Neuromuscular lBlocking lAgents)
19. lDiuretic lAgents
20. lDrugs lAffecting lthe lCentral lNervous lSystem
21. lVasopressors, lInotropes, land lAntiarrythmic lAgents
22. lDrugs lAffecting lCirculation: lAntihypertensives, lAntianginals, lAntithrombotics
23. lSleep land lSleep lPharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
l l l l l l
l Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
l l l l l l
MULTIPLE lCHOICE
1. What lis lthe lname lof lthe lreceptor lsites lthat lare llocated lin lthe lperipheral lvasculature, lthe lheart,
lbronchial lmuscle, land lbronchial lblood lvessels?
a. Beta l2 lreceptors c. Alpha lreceptors
b. Gamma lreceptors d. l l Beta l1 lreceptors
ANS: l C
Alpha lreceptors lare llocated lin lthe lperipheral lvasculature, lthe lheart, lbronchial lmuscle, land lbronchial
lblood lvessels.
PTS: l 1
2. Which lreceptor lsite lresults lin ltachycardia, lan lincreased lpotential lfor larrhythmias, land lan
lincreased lcardiac loutput?
a. Beta l1 lreceptor c. Alpha lreceptor
b. Beta l2 lreceptor d. l Delta lreceptor
ANS: l A
Stimulation lof lthe lbeta-1 lreceptors lresults lin ltachycardia, lan lincreased lpotential lfor larrhythmias,
land lan lincreased lcardiac loutput. lIn ladministering ldrugs lto lthe lpulmonary lsystem, lstimulation lof lthe
lbeta-1 lsites lis lnot ldesired. lHowever, lmost lrespiratory lpharmacologic lagents lhave lsome lbeta-1
lstimulatory leffect.
PTS: l 1
3. Stimulation lof lthe lbeta l2 lreceptors lcauses l
a. peripheral lvasoconstriction land lmild lbronchoconstriction lin lthe llungs.
b. tachycardia, lan lincreased lpotential lfor larrhythmias, land lan lincreased lcardiac loutput.
c. bronchodilation.
d. peripheral lvasodilation, lbradycardia, land ldecreased lcardiac loutput.
ANS: l C
Stimulation lof lthe lbeta-2 lreceptors lin lthe llungs lcauses lbronchodilation.
PTS: l 1
4. Acetylcholine lstimulates l
a. the lVagus lnerve.
b. the ladrenergic lreceptors.
c. the lsympathetic lnervous lsystem.
d. the lcholinergic lreceptors.
ANS: l D
Acetylcholine lstimulates lthe lcholinergic lreceptors.
PTS: l 1
5. What limmunoglobulin lantibody lsensitizes lthe lmast lcell?
a. Leukotrienes c. Histamine
, b. IgE d. l Prostaglandins
ANS: l B
The lIgE l(reagin) lantibodies lsensitize lthe lmast lcell. lRepeated lexposure lto lthe lantigen lcauses lthe
ldegranulation lof lthe lmast lcell.
PTS: l 1
6. Which lof lthe lfollowing lis lcaused lby lhistamine lrelease lfrom lthe lmast lcells?
I. Bronchodilation
II. Increased lbronchial lgland lsecretion
III. Increased lamount lof lmucus lpresent lin lthe lairways
a. I land lII lonly c. III lonly
b. II land lIII lonly d. l l I, lII, lIII
ANS: l B
Histamine lis lalso la lpotent lbronchoconstrictor. lIn laddition lto lits lbronchoconstrictive lactivity, lhistamine
II) lincreases lbronchial lgland lsecretion, lcausing lIII) lan lincrease lin lthe lamount lof lmucus
lpresent lin lthe lairways. lHistamine lmay lalso lhave lan leffect lon lvascular lpermeability lsimilar lto
lthe leffect lof- lSRS-A.
PTS: l 1
7. A lsympathomimetic ldrug lwould lcause l
a. bronchodilation. c. Histamine lrelease.
b. bronchoconstriction. d. l Vagus lnerve lstimulation.
ANS: l A
A lsympathomimetic ldrug lwould lcause lbronchodilation. lSympathomimetic lagents lare lthe ldrugs lmost
lcommonly lused lto lreverse lbronchospasm.
PTS: l 1
8. Stimulation lof lthe lsympathetic lnervous lsystem lcauses l
a. vascular lpermeability. c. bronchodilation.
b. decreased lblood lpressure. d. l bronchoconstriction.
ANS: l C
Sympathetic lnervous lsystem lstimulation lcauses lbronchodilation.
PTS: l 1
9. Which lof lthe lfollowing lwould lNOT lcause la lbronchospasm lor lbronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta l1 lreceptors d. l Prostaglandins
ANS: l B
Beta-1 lreceptors lwould lnot lcause la lbronchospasm lor lbronchoconstriction. lLeukotrienes lare lone
lof lmany lchemical lmediators lreleased lby lthe lmast lcells. lLeukotrienes lcause la ldirect, lstrong
lbronchoconstriction. lHistamine lis lalso la lpotent lbronchoconstrictor. lProstaglandins lcause la lstrong
lbronchospasm, lespecially lin lasthmatic lpatients.
PTS: l 1